tm logo

Monitor this mark

View On USPTO

AFLURIA QUADRIVALENT INFLUENZA VACCINE
Live/Registered
REGISTERED

on 26 Dec 2017

Last Applicant/ Owned by

CSL Limited

Melbourne VIC 3000

AU

Serial Number

79212213 filed on 06th Jan 2017

Registration Number

5362179 registered on 26th Dec 2017

in the Principal Register

Correspondent Address

Nancy Sabarra

Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.

New York, NY 10036

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

AFLURIA QUADRIVALENT INFLUENZA VACCINE

Pharmaceutical preparations and substances for the prevention or treatment of influenza; influenza vaccines

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations and substances for the prevention or treatment of influenza; influenza vaccines

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79212213

Mark Type

No Service/Collective Mark

Attorney Docket Number

No CSLL 1912151

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.13.14 -

Three or more quadrilaterals

26.13.21 -

Quadrilaterals that are completely or partially shaded

Legal History

Show more

Status DateAction Taken
06th Jun 2024TEAS SECTION 71 & 15 RECEIVED
31st Mar 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
26th Dec 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25th Nov 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25th Nov 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17th Dec 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17th Dec 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19th May 2018FINAL DECISION TRANSACTION PROCESSED BY IB
06th Apr 2018FINAL DISPOSITION NOTICE SENT TO IB
06th Apr 2018FINAL DISPOSITION PROCESSED